Aflibercept
Aflibercept is an approved active ingredient.
Pharmaceutical drug
What it is used for
- Macular retinal edema
- Kuhnt-Junius degeneration
- Retinal vein occlusion
- Colon cancer
- Rectum cancer
- Diabetic retinopathy
- Colorectal neoplasm
- Retinal neovascularization
- Neoplasm
- Degenerative myopia
- Complications of diabetes mellitus
ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.
Treatment of metastatic colorectal cancer (MCRC).
How it works
- Vascular endothelial growth factor A inhibitor
- Placenta growth factor inhibitor
Common side effects
The following clinically significant adverse reactions are described elsewhere in the labeling: Hemorrhage Gastrointestinal Perforation Impaired Wound Healing Fistula Formation Hypertension Arterial Thromboembolic Events Proteinuria Neutropenia and Neutropenic Complications Diarrhea and Dehydration Reversible…
Pregnancy and breastfeeding
Based on findings from animal reproduction studies and its mechanism of action, ZALTRAP can cause fetal harm when administered to pregnant women.
Brand names
United States
Zaltrap
European Union
Afiveg · Afqlir · Baiama · Eiyzey · Eydenzelt · Eyluxvi · Mynzepli · Vgenfli · Zaltrap
Canada
Aflivu · Eydenzelt
Approval status
- US Food and Drug Administration
- prescription · since 2011
- European Medicines Agency
- authorised · since 2012
- Health Canada
- prescription · marketed
- First approval anywhere
- 2011
Codes
- ATC
- L01XX44, S01LA05
- RxNorm CUI
- 1232150
- ChEMBL
- CHEMBL1742982
- Wikidata
- Q4689286
Frequently asked questions
What is Aflibercept used for?
Aflibercept is used for: Macular retinal edema, Kuhnt-Junius degeneration, Retinal vein occlusion, Colon cancer, Rectum cancer, Diabetic retinopathy, Colorectal neoplasm, and Retinal neovascularization.
What are the brand names of Aflibercept?
Brand names of Aflibercept include Zaltrap, Afiveg, Afqlir, Baiama, Eiyzey, Eydenzelt, Eyluxvi, and Mynzepli.
Medicines in the same class
- Arsenic trioxide
- Celecoxib
- Tretinoin
- Hydroxycarbamide
- Irinotecan
- Bortezomib
- Anagrelide
- Miltefosine
- Pegaspargase
- Bevacizumab
- Ranibizumab
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)